Nitschké Maximilian, Bell Alexander, Karaman Sinem, Amouzgar Meelad, Rutkowski Joseph M, Scherer Philipp E, Alitalo Kari, McDonald Donald M
Department of Anatomy, Cardiovascular Research Institute, and UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.
Wihuri Research Institute and Translational Cancer Biology Research Program, University of Helsinki, Helsinki, Finland.
Am J Pathol. 2017 Sep;187(9):1984-1997. doi: 10.1016/j.ajpath.2017.05.009. Epub 2017 Jul 3.
Chylous pleural effusion (chylothorax) frequently accompanies lymphatic vessel malformations and other conditions with lymphatic defects. Although retrograde flow of chyle from the thoracic duct is considered a potential mechanism underlying chylothorax in patients and mouse models, the path chyle takes to reach the thoracic cavity is unclear. Herein, we use a novel transgenic mouse model, where doxycycline-induced overexpression of vascular endothelial growth factor (VEGF)-C was driven by the adipocyte-specific promoter adiponectin (ADN), to determine how chylothorax forms. Surprisingly, 100% of adult ADN-VEGF-C mice developed chylothorax within 7 days. Rapid, consistent appearance of chylothorax enabled us to examine the step-by-step development in otherwise normal adult mice. Dynamic imaging with a fluorescent tracer revealed that lymph in the thoracic duct of these mice could enter the thoracic cavity by retrograde flow into enlarged paravertebral lymphatics and subpleural lymphatic plexuses that had incompetent lymphatic valves. Pleural mesothelium overlying the lymphatic plexuses underwent exfoliation that increased during doxycycline exposure. Together, the findings indicate that chylothorax in ADN-VEGF-C mice results from retrograde flow of chyle from the thoracic duct into lymphatic tributaries with defective valves. Chyle extravasates from these plexuses and enters the thoracic cavity through exfoliated regions of the pleural mesothelium.
乳糜胸常伴有淋巴管畸形和其他存在淋巴缺陷的病症。尽管在患者和小鼠模型中,乳糜从胸导管逆流被认为是乳糜胸潜在的发病机制,但乳糜到达胸腔的路径尚不清楚。在此,我们使用一种新型转基因小鼠模型,其中多西环素诱导的血管内皮生长因子(VEGF)-C过表达由脂肪细胞特异性启动子脂联素(ADN)驱动,以确定乳糜胸的形成方式。令人惊讶的是,100%的成年ADN-VEGF-C小鼠在7天内出现了乳糜胸。乳糜胸迅速且一致地出现,使我们能够在其他方面正常的成年小鼠中检查其逐步发展过程。用荧光示踪剂进行动态成像显示,这些小鼠胸导管中的淋巴液可通过逆流进入扩大的椎旁淋巴管和胸膜下淋巴丛,这些淋巴管和淋巴丛的淋巴瓣膜功能不全。覆盖淋巴丛的胸膜间皮发生剥脱,在多西环素暴露期间剥脱增加。这些发现共同表明,ADN-VEGF-C小鼠的乳糜胸是由于乳糜从胸导管逆流至瓣膜有缺陷的淋巴支流所致。乳糜从这些淋巴丛渗出,并通过胸膜间皮的剥脱区域进入胸腔。